Drug Shortage Report for APO-IBUPROFEN
| Report ID | 67023 |
| Drug Identification Number | 00506052 |
| Brand name | APO IBUPROFEN TAB 400MG |
| Common or Proper name | IBUPROFEN TAB 400MG |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IBUPROFEN |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1000 BTL |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-11-12 |
| Estimated end date | Unknown |
| Actual end date | 2018-12-07 |
| Shortage status | Resolved |
| Updated date | 2018-12-08 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.